【us:Iclusig】Ponatinib 45mg/tablet 30tablets/bottle

$300.00

Ponatinib 45mg/tablet 30tablets/bottleg is an AISTIKA-listed generic product from Laos Alliance Pharma. Its active ingredient is Ponatinib.

Category:
Guaranteed Safe Checkout

Product Information:

  • Product name: Ponatinib 45mg
  • Manufacturer / brand: Laos Alliance
  • Active ingredient: Ponatinib
  • Current strength:45mg
  • SKU: 11-L-1417
  • Site category:  chronic myeloid leukemia (CML),

Active Ingredient and Reference Data

Ponatinib is the active ingredient used for this product page. Public prescribing information for Ponatinib was used for the medical reference sections. Medical details are provided for reference and must be interpreted by a qualified healthcare professional.


Mechanism of Action

Ponatinib (Iclusig) is a third-generation pan-mutational BCR-ABL tyrosine kinase inhibitor whose ethynyl linker enables binding to the T315I-mutated BCR-ABL kinase domain, inhibiting proliferation driven by all known BCR-ABL point mutations—including T315I—in CML and Ph+ ALL.


Storage and Purchase Notes

Store according to the package or pharmacist instructions and keep out of reach of children. Before ordering, confirm product name, strength, quantity, price, shipping details, and payment method. After receipt, check packaging, batch number, expiration date, and storage conditions.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Shopping Cart